Phio Pharmaceuticals | 8-K: Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Phio Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | DEFA14A: Others
Phio Pharmaceuticals | DEF 14A: Definitive information statements
Phio Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | 8-K: Current report
Phio Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
Phio Pharmaceuticals | 8-K: Current report
No Data
No Data